Profil
Bob Ai is currently a Managing Partner at Goby Global LLC.
Previously, he worked as a Managing Director at Solebury Strategic Communications LLC.
He also served as the Chief Financial Officer & Director at Edoc Acquisition Corp.
from 2022 to 2024.
Dr. Ai has a background in finance and research, having held positions such as Research Analyst at Merlin Biomed Group Hedge Funds and WallachBeth Capital LLC.
He has also worked as a Technical Consultant at Maverick Capital Ltd. and as a Summer Associate at Credit Suisse Securities (USA) LLC.
Dr. Ai holds an MBA and a doctorate from The Pennsylvania State University, as well as a graduate degree from the same institution.
Postes actifs de Bob Ai
| Sociétés | Poste | Début |
|---|---|---|
Goby Global LLC | Corporate Officer/Principal | - |
Anciens postes connus de Bob Ai
| Sociétés | Poste | Fin |
|---|---|---|
| EDOC ACQU | Directeur Financier/CFO | 21/03/2024 |
WallachBeth Capital LLC
WallachBeth Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/09/2016 |
| AOXING PHARMACEUTICAL COMPANY, INC. | Directeur Financier/CFO | 01/07/2012 |
Merlin Nexus
Merlin Nexus Investment ManagersFinance Merlin Nexus invests in both private and public life sciences companies across the globe. The firm focuses on sectors such as biotechnology, medical devices, molecular diagnostics, and specialty pharmaceuticals. It participates in late-stage and PIPE (Private Investments in Public Equity) transactions. | Private Equity Investor | 31/05/2011 |
Wall Street Access LLC
Wall Street Access LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 30/06/2007 |
Formation de Bob Ai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Maverick Capital Ltd.
Maverick Capital Ltd. Investment ManagersFinance Maverick’s investment process is driven by intensive, fundamental bottom-up research. They deploy capital to individual investment opportunities that they believe offer the highest returns relative to risk, regardless of index weightings, market capitalization, or style orientations. Their research is augmented by a top-down view of individual industries and the efforts of their quantitative research team. The firm’s investment team is organized into four industry sector teams: consumer, healthcare, cyclicals, and technology. The industry sector teams are supported by two disciplined research teams (private investments and quantitative).; | Finance |
Bennett Lawrence Management LLC
Bennett Lawrence Management LLC Investment ManagersFinance Bennett Lawrence Management (BLM) conducts in-house primary research to identify unique, high growth investment opportunities. Their strategies include: the Bennett Lawrence Growth Equity Composite, the Bennett Lawrence Mid-Cap Composite, The Bennett Lawrence Growth Equity Composite is an all-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios in this strategy. The market-caps of these portfolios fluctuate depending upon market conditions. BLM's growth equity portfolios are suitable for investors seeking long-term capital appreciation. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Mid-Cap Composite is a mid-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. 80% of the portfolio's equity market value is typically invested in the stocks of companies with a market-cap of $15 billion or less at cost. In general, the weighted average market-cap of the portfolio will be no more than 1.5 times the weighted average capitalization of the Russell Midcap Growth Index. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Small-Cap Composite is a small-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. In general, 75% of BLM's small-cap portfolios' holdings will be in the shares of companies with a market-cap of $2.5 billion or less at the time of initial purchase. Portfolios seek to provide long-term growth investors a way to access growth opportunities in the shares of smaller companies. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. BLM's long/short seeks to amplify the core concepts of their growth investment approach through the use of leverage and short positions. The firm seeks to capitalize on the lack of Wall Street research coverage among smaller and mid-sized companies. They select long positions that can capitalize on the long-term earnings growth potential of competitively advantaged companies that are benefiting from strong demand trends. BLM's short positions focus on the shares of companies that have deteriorating growth prospects. The firm manages market risk through the use of both company specific short positions short sales of ETFs. | Finance |
Merlin Biomed Group Hedge Funds
Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs. | Finance |
Wall Street Access LLC
Wall Street Access LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
WallachBeth Capital LLC
WallachBeth Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merlin Nexus
Merlin Nexus Investment ManagersFinance Merlin Nexus invests in both private and public life sciences companies across the globe. The firm focuses on sectors such as biotechnology, medical devices, molecular diagnostics, and specialty pharmaceuticals. It participates in late-stage and PIPE (Private Investments in Public Equity) transactions. | Finance |
Aoxing Pharmaceutical Co., Inc.
Aoxing Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies narcotics and pain management products | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Commercial Services |
Edoc Acquisition Corp.
Edoc Acquisition Corp. Financial ConglomeratesFinance Operates as an blank check company | Finance |
Goby Global LLC |
















